Eli Lilly spends $3.2 billion on Morphic's oral integrin inhibitor for inflammatory bowel disease.
作者信息
Mullard Asher
出版信息
Nat Rev Drug Discov. 2024 Sep;23(9):650. doi: 10.1038/d41573-024-00119-y.
PMID:39026040
Abstract
摘要
Mullard Asher
Nat Rev Drug Discov. 2024 Sep;23(9):650. doi: 10.1038/d41573-024-00119-y.
Nat Rev Drug Discov. 2024-9
Nat Biotechnol. 2014-3
Expert Opin Biol Ther. 2014-12
Inflamm Bowel Dis. 2014-10
J Crohns Colitis. 2017-8-1
World J Gastroenterol. 2018-5-7
Gastroenterol Clin North Am. 2014-9
Nat Rev Drug Discov. 2013-6
J Gastroenterol Hepatol. 2018-9
J Gastroenterol Hepatol. 2016-6
Curr Opin Gastroenterol. 2025-7-1
Zotero 插件